プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. C. Ernesto F.に依頼

Spain

Freelance Statistician & Clinical Researcher

プロフィール概要

I am currently working as freelance on clinical research, and descriptive and inferential statistics, such as regressions. I have a strong cardiovascular background, but wide experience in different medical specialities, as I have worked in collaboration with Cardiology, Pneumology, Internal Medicine, Gastroenterology Psychiatry and Radiology Services across different hospitals. Throughout my career, I have obtained a posdoctoral grant (Sara Borrell in 2020) and several competitive contracts. As a result, I have more than 10-year experience in scientific research, with a wide scope due to the high transversality of the different projects I have worked in.

専門分野

• ★ Biostatistics
• ★ SPSS
• ★ Technical & Scientific Writing
• ☆ Statistics
• ☆ Regression Analysis
• ☆ Nonlinear Regression
• ☆ Excel
• ☆ Human Biology
• ☆ Sleep Medicine
• ☆ Gastroenterology & Hepatology
• ☆ Hepatitis
• ☆ Cardiovascular Disease
• ☆ Vascular Medicine
• ☆ Clinical Laboratory Science
• ☆ Clinical Biochemistry
• ☆ Public Health
• ☆ Epidemiology
• ☆ Hypothesis
• ☆ Peer Review
• ☆ Research Methodology
• ☆ Manuscript & Journal Article Writing

サービス

• Writing
• Research
• Consulting
• Data & AI

Writing General Proofreading & Editing, Translation

Research Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis

職務経験

Clinical Researcher & Biostatistician

Freelancer

2月 2024 - 現在

Posdoctoral researcher

Hospital Universitario Santa Cristina

1月 2021 - 1月 2024

Lab Manager/Post Doc

Universidad Complutense de Madrid

6月 2018 - 12月 2020

Predoctoral Researcher

Instituto de Investigación Sanitaria Fundación Jiménez Díaz

7月 2011 - 2月 2017

学歴

Ph.D., Pharmacology and Physiology

Universidad Autónoma de Madrid - Spain

10月 2012 - 2月 2017

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

et al., Fernández-García CE, Gallego-Galiana J, Solís-Muñoz PA, Del Pozo-Maroto E, Domínguez-Alcón L, Tobar-Izquierdo M, Sáez A, Rodríguez de Cía J, Magaña-Sánchez A, Real-Martínez Y (2024). Hospital-based screening outperforms primary care screening as a means of achieving hepatitis C virus micro-elimination . Infectious diseases now.

Pablo Solís‐Muñoz, María de la Flor‐Robledo, Carlos E. Fernández‐García, Águeda González‐Rodríguez, Carmelo García‐Monzón (2023). Editorial: mitochondrial respiratory chain activity—a potential link with disease severity and treatment response in alcoholic hepatitis. Authors' reply . Alimentary Pharmacology & Therapeutics.

Pablo Solís‐Muñoz, María de la Flor‐Robledo, Inmaculada García‐Ruíz, Carlos E. Fernández‐García, Águeda González‐Rodríguez, Naina Shah, Ramón Bataller, Michael Heneghan, Carmelo García‐Monzón, José A. Solís‐Herruzo (2023). Mitochondrial respiratory chain activity is associated with severity, corticosteroid response and prognosis of alcoholic hepatitis . Alimentary Pharmacology & Therapeutics.

Marañón P, Isaza SC, Fernández-García CE, Rey E, Gallego-Durán R, ROCIO MONTERO VALLEJO, de Cía JR, Ampuero J, Valverde ÁM, Romero-Gómez M, et al. (2023). Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis . Biomarker research.

Landete P, Fernández-García CE, Muñoz JM, Friera A, julio Ancochea, Águeda González-Rodríguez, García-Monzón C (2023). Sleep apnea-COPD overlap syndrome is associated with larger left carotid atherosclerotic plaques . Frontiers in cardiovascular medicine.

Marañón P, Fernández-García CE, Isaza SC, Rey E, Gallego-Durán R, ROCIO MONTERO VALLEJO, de Cía JR, Ampuero J, Romero-Gómez M, García-Monzón C, et al. (2022). Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool . Biomarker research.

Landete P, Fernández-García CE, Aldave-Orzaiz B, Hernández-Olivo M, Acosta-Gutiérrez CM, Zamora-García E, julio Ancochea, Águeda González-Rodríguez, García-Monzón C (2022). Increased Oxygen Desaturation Time During Sleep Is a Risk Factor for NASH in Patients With Obstructive Sleep Apnea: A Prospective Cohort Study . Frontiers in medicine.

Fernandez-García CE, Roldan-Montero R, Tarin C, Martinez-Lopez D, Pastor-Vargas C, Luis Miguel Blanco-Colio, JOSE LUIS MARTIN-VENTURA (2018). Lipocalin-2, a potential therapeutic target in advanced atherosclerosis . Atherosclerosis.

Fernandez-García CE, Tarin C, Roldan-Montero R, Martinez-Lopez D, Torres-Fonseca M, Lindhot JS, Vega de Ceniga M, Egido J, Natalia Lopez-Andres, Luis Miguel Blanco-Colio, et al. (2017). Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development . Clinical science (London, England : 1979).

Fernandez-García CE, Burillo E, Jes Lindholt, Diego Martínez López, Katrine Pilely, Carla Mazzeo, Michel JB, Egido J, Peter Garred, Luis Miguel Blanco-Colio, et al. (2017). Association of ficolin-3 with abdominal aortic aneurysm presence and progression . Journal of thrombosis and haemostasis : JTH.

Nuria Beneit, Fernández-García CE, JOSE LUIS MARTIN-VENTURA, Perdomo L, Oscar Escribano, Michel JB, García-Gómez G, Fernández S, Díaz-Castroverde S, Egido J, et al. (2016). Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis . Cardiovascular diabetology.

Tarín C, Fernandez-Garcia CE, Burillo E, Pastor-Vargas C, Llamas-Granda P, Castejón B, Ramos-Mozo P, Torres-Fonseca MM, Berger T, Mak TW, et al. (2016). Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice . Cardiovascular research.

Burillo E, Tarin C, Torres-Fonseca MM, Fernandez-García CE, Martinez-Pinna R, Diego Martínez López, Llamas-Granda P, Camafeita E, Juan Antonio Lopez, Vega de Ceniga M, et al. (2016). Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression . Clinical science (London, England : 1979).

Julio Madrigal-Matute, Fernandez-Garcia CE, Luis Miguel Blanco-Colio, Burillo E, Ana Fortuño, Martinez-Pinna R, Llamas-Granda P, Beloqui O, Egido J, Zalba, G., et al. (2015). Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis . Free radical biology & medicine.

Julio Madrigal-Matute, Jes Lindholt, Fernandez-Garcia CE, Alberto Benito Martin, Burillo E, Zalba, G., Beloqui O, Llamas-Granda P, Ortiz A, Egido J, et al. (2014). Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis . Journal of the American Heart Association.

JOSE LUIS MARTIN-VENTURA, Julio Madrigal-Matute, Martinez-Pinna R, Ramos-Mozo P, Luis Miguel Blanco-Colio, Moreno JA, Tarin C, Burillo E, Fernandez-Garcia CE, Egido J, et al. (2012). Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options . Thrombosis and haemostasis.

Julio Madrigal-Matute, Martinez-Pinna R, Fernandez-Garcia CE, Ramos-Mozo P, Burillo E, Egido J, Luis Miguel Blanco-Colio, JOSE LUIS MARTIN-VENTURA (2012). Cell stress proteins in atherothrombosis . Oxidative medicine and cellular longevity.

Julio Madrigal-Matute, Fernandez-Garcia CE, Gomez-Guerrero C, Oscar Lopez-Franco, Muñoz-Garcia B, Egido J, Luis Miguel Blanco-Colio, JOSE LUIS MARTIN-VENTURA (2012). HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis . Cardiovascular research.